Fundz
Following Locus Cell?

Get the free weekly contract digest

The latest new contracts, like Locus Cell’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Locus Cell Partners with Cambium Bio for Phase III CDMO Manufacturing of Elate Ocular®.

Sep 29, 20259 months ago

Contract Type

partnership

TaiwanManufacturingBiotechnology

Description

Locus Cell has signed a Memorandum of Understanding with Cambium Bio for the contract development and manufacturing of Elate Ocular® related therapies. This partnership marks Locus Cell's first Phase III international CDMO project, enhancing their role in global pharmaceutical manufacturing.

Company Information

Company

Locus Cell

Location

Taiwan

About

Locus Cell is a leading regenerative medicine contract development and manufacturing organization (CDMO) based in Taiwan. The company specializes in providing innovative solutions for pharmaceutical and biotechnology partners. It boasts state-of-the-art facilities that comply with international regulatory standards, including FDA requirements.

Predictive Intelligence
Strategic

ML-powered predictions for Locus Cell's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.